MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$80,547,000
EPS
-$0.52
Unit: Dollar
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
License and other revenue
0
0
0
0
Research and development
59,891,000
54,477,000
41,563,000
42,741,000
General and administrative
19,882,000
13,995,000
12,227,000
11,912,000
Loss from operations
-79,773,000
-68,472,000
-53,790,000
-54,653,000
Interest and investment income
5,138,000
4,492,000
3,765,000
4,380,000
Interest expense
2,731,000
2,808,000
2,890,000
2,884,000
Loss on extinguishment of debt
-
0
-
-
Other non-operating income (expense), net
-1,025,000
103,000
-1,810,000
3,592,000
Loss before income taxes
-78,391,000
-66,685,000
-54,725,000
-49,565,000
Income tax expense
850,000
-522,000
166,000
778,000
Net loss
-79,241,000
-66,163,000
-54,891,000
-50,343,000
Foreign currency translation adjustment
-580,000
190,000
691,000
-479,000
Unrealized (loss) gain on available for sale securities during period, net of tax of 0.2 million in 2026 and 0 in 2025
-483,000
60,750*
-
-
Unrealized (loss) gain on available for sale marketable securities, net of reclassification adjustment and tax
-
-
318,000
-5,000
Reclassification adjustment for realized net (loss) gain on available for sale marketable securities included in net loss, net of tax of 0.1 million in 2026 and 0.8 million in 2025
243,000
136,750*
-
-
Other comprehensive (gain) income
-1,306,000
114,000
1,009,000
-484,000
Total comprehensive loss
-80,547,000
-66,049,000
-53,882,000
-50,827,000
Basic EPS
-0.52
-0.465
-0.41
-0.38
Diluted EPS
-0.52
-0.465
-0.41
-0.38
Basic Average Shares
153,549,733
141,987,994
134,163,492
133,677,405
Diluted Average Shares
153,549,733
141,987,994
134,163,492
133,677,405
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Total comprehensiveloss-$80,547,000 (-184.89%↓ Y/Y)Net loss-$79,241,000 (-203.20%↓ Y/Y)Other comprehensive(gain) income-$1,306,000 (38.91%↑ Y/Y)Loss before incometaxes-$78,391,000 (-216.88%↓ Y/Y)Income tax expense$850,000 (-39.16%↓ Y/Y)Foreign currencytranslation adjustment-$580,000 (-190.20%↓ Y/Y)Unrealized (loss) gain onavailable for sale...-$483,000 Reclassification adjustment forrealized net (loss) gain...$243,000 Interest and investmentincome$5,138,000 (-34.88%↓ Y/Y)Loss from operations-$79,773,000 (-159.20%↓ Y/Y)Interest expense$2,731,000 (-5.07%↓ Y/Y)Other non-operatingincome (expense), net-$1,025,000 (-199.90%↓ Y/Y)Research and development$59,891,000 (79.08%↑ Y/Y)General andadministrative$19,882,000 (61.20%↑ Y/Y)

Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals plc (CNTA)